benign neoplasm: A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites.
Check pre-conditions None
Check conditions None
Apply sex-specific rule None
CD2_BENIGN_OTHER_NOS
Extra metadata
List of similar endpoints to
Benign neoplasm of other and unspecified sites
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 558 | 331 | 227 |
| Unadjusted prevalence (%) | 0.21 | 0.23 | 0.20 |
| Mean age at first event (years) | 46.84 | 45.44 | 48.88 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.02 | 1.54 [0.74, 3.17] | 2.5e-1 | 54 |
| 15 years | 0.01 | 1.57 [0.86, 2.87] | 1.4e-1 | 37 |
| 5 years | 0.00 | 2.74 [1.44, 5.21] | 2.1e-3 | 16 |
| 1 year | - | - | - | - |
Index endpoint: CD2_BENIGN_OTHER_NOS – Benign neoplasm of other and unspecified sites
GWS hits: 0
before Benign neoplasm of other and unspecified sites
after Benign neoplasm of other and unspecified sites
Loading survival analyses plot
Loading survival analyses table
